Clinical Trial Update: Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting completed results for lifitegrast 5% in treating dry eye in habitual soft contact lens wearers; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• Xiidra (lifitegrast ophthalmic solution) 5% (lifitegrast)

Snippet

Sponsor: State University of New York College of Optometry | Conditions: Dry Eye | Phase 4 | Status: COMPLETED | Results posted: 2025-01-14